| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 1 | +100.00% | -1.77% | +1.12% | -2.89% | -2.89% | — |
| 14d | 1 | +0.00% | +8.55% | +1.24% | +7.31% | +7.31% | — |
| 30d | 1 | +0.00% | +6.04% | +1.47% | +4.57% | +4.57% | — |
| 60d | 1 | +100.00% | -2.80% | +0.65% | -3.45% | -3.45% | — |
| 90d | 1 | +100.00% | -37.15% | -4.63% | -32.52% | -32.52% | — |
| 180d | 1 | +100.00% | -42.48% | +6.90% | -49.38% | -49.38% | — |
| 1y | 1(1 pending) | — | — | — | — | — | — |
| 2y | 1(1 pending) | — | — | — | — | — | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| VRDN VIRIDIAN THERAPEUTICS, INC.DE | SALE Chief Legal Officer | 1,724 | $29.32 | $50.5K | 3,445 | Mar 3, 2026 | Mar 4, 2026 ↗ | View → |
| VRDN VIRIDIAN THERAPEUTICS, INC.DE | SALE Chief Legal Officer | 5,169 | — | — | 15,510 | Mar 3, 2026 | Mar 4, 2026 ↗ | View → |
| VRDN VIRIDIAN THERAPEUTICS, INC.DE | PURCHASE Chief Legal Officer | 5,169 | — | — | 5,169 | Mar 3, 2026 | Mar 4, 2026 ↗ | View → |
| VRDN VIRIDIAN THERAPEUTICS, INC.DE | SALE Chief Legal Officer | 1,675 | $30.19 | $50.6K | 3,494 | Mar 3, 2026 | Mar 9, 2026 ↗ | View → |
| VRDN VIRIDIAN THERAPEUTICS, INC.DE | PURCHASEGRANT Stock grant | 23,850 | — | — | 23,850 | Mar 2, 2026 | Mar 4, 2026 ↗ | View → |
| VRDN VIRIDIAN THERAPEUTICS, INC.DE | PURCHASEGRANT Stock grant | 119,300 | — | — | 119,300 | Mar 2, 2026 | Mar 4, 2026 ↗ | View → |
| VRDN VIRIDIAN THERAPEUTICS, INC.DE | SALE Chief Legal Officer | 2,272 | $31.16 | $70.8K | 0 | Dec 31, 2025 | Jan 2, 2026 ↗ | View → |
| VRDN VIRIDIAN THERAPEUTICS, INC.DE | PURCHASEGRANT Stock grant | 20,679 | — | — | 20,679 | Mar 3, 2025 | Mar 4, 2025 ↗ | View → |
| VRDN VIRIDIAN THERAPEUTICS, INC.DE | PURCHASEGRANT Stock grant | 124,072 | — | — | 124,072 | Mar 3, 2025 | Mar 4, 2025 ↗ | View → |
| VRDN VIRIDIAN THERAPEUTICS, INC.DE | PURCHASEGRANT Stock grant | 290,000 | — | — | 290,000 | Feb 12, 2024 | Feb 14, 2024 ↗ | View → |